Abstract
Neonatal blood spot testing is offered to all babies in the first week of life as part of the UK Newborn Screening Programme. A blood sample is taken from the heel and used to screen for phenylketonuria, congenital hypothyroidism, cystic fibrosis, sickle cell diseases and medium-chain acyl-CoA dehydrogenase deficiency. This article aims to discuss the principles of screening as applied to neonatal blood spot testing, the blood spot test and the conditions which screening aims to detect.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: InnovAiT: Education and inspiration for general practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
